LYRA - Lyra Therapeutics to Participate in Upcoming Investor Conferences | Benzinga

WATERTOWN, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (NASDAQ:LYRA), a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS), today announced that Maria Palasis, Ph.D., President and Chief Executive Officer, will participate in the following investor conferences in November:

• Jefferies London Healthcare Conference 2023 – Fireside chat on Thursday, November 16^th at 1:30 p.m. GMT
• Piper Sandler 35^th Annual Healthcare Conference – Presentation on Wednesday, November 29^th at 9:30 a.m. ET

Live webcast of the presentations will be available on ...

Full story available on Benzinga.com